NEW YORK, NY / ACCESSWIRE / March 28, 2017 / Superconductor Technologies and Gevo have both been acknowledged for their innovation – one company being awarded a patent, the other being recognized by a distinguished group of peers. Both companies will be releasing their 4th quarter and year-end financials this week, giving investors hope the notoriety will translate into future earnings.
RDI Initiates Coverage:
Superconductor Technologies, Inc. https://ub.rdinvesting.com/news/?ticker=SCON
Gevo, Inc. https://ub.rdinvesting.com/news/?ticker=GEVO
Superconductor Technologies advanced 19.38% to close at $1.54 on Monday. The stock traded between $1.65 and $1.29 on volume of 4,808,008 shares traded. Several factors spurred the price of the technology company. On February 21st, it had been awarded a patent for a key feature of the RCE-CDR system. The patent, U.S. Patent No. 9,567,661 named "Reactor Device With Removable Deposition Monitor" will improve cycle time, create higher throughput, and lower overall costs. Prior to this, on February 16th, the company also received patents No. 9,564,258 for unique wire manufacturing process. The company will announce its 4th quarter and year-end 2016 financial results prior to the market opening on Tuesday, March 28th. Later in the day, there will be a follow up with a scheduled conference call to be held at 11:00 ET to discuss the results.
Access RDI's Superconductor Research Report at: https://ub.rdinvesting.com/news/?ticker=SCON
Gevo advanced 13.27% to close at $1.28 on Monday. The stock traded between $1.30 and $1.10 on volume of 3,126,891 shares traded. The stock is in the news as the company's planned release of 4th quarter financials on the afternoon of March 29th at 4:30 EDT. The second is connected to the first, which involves the company's announcement back on March 6th of this year that "The Digest," a global bioeconomy daily publication that is the industry's most widely read publication, had awarded Gevo the number 10 rank in its 2017 edition. The special section, titled, "50 Hottest Companies in the Advanced Bioeconomy", arrives at its rankings by the selection of a prestigious group of specialists in the industry. Gevo specializes in the development and marketing of alternatives to petroleum-based products and it has recently raised $11.9 million by offering common stocks and warrants to strengthen its balance sheet.
Access RDI's Gevo Research Report at: https://ub.rdinvesting.com/news/?ticker=GEVO
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Hemal K. Gandhi, a CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.